The most common risk factor for developing lipodystrophy is taking protease inhibitors and nucleoside reverse transcriptase inhibitors to treat HIV for an extended period of time. Demographic risk factors include age, such that older individuals are at higher risk and race, with Caucasians reporting it more often. Gender often determines how you experience lipodystrophy. Males more commonly experience fat loss in their arms or legs, while women tend to experience an increase in breast size and abdominal fat. Other risk factors include having a higher baseline body mass index, usually in the obese range. Extreme weight changes, the length and severity of your HIV infection, your baseline immune system health, and how well your immune system recovers after taking HIV medications are also contributing factors. More causes of Lipodystrophy include:
--Nelfinavir
--Hutchinson-Gilford progeria syndrome
--Partial lipodystrophy
--Benign symmetrical lipomatosis of Madelung
--Berardinelli lipodystrophy syndrome
--SHORT syndrome
--Focal facial dermal dysplasia
--Insulin receptor defect with insulin-resistant diabetes
--Stavudine
--Familial lipodystrophy of extremities and body
--Wiedermann-Rautenstrauch syndrome
--Zidovudine
--Acquired generalized lipodystrophy